• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Johnson & Johnson

Johnson & Johnson

Johnson & Johnson JNJ 3 Star

Last Price$102.20Day Change (%)0.01%
Open Price$102.34Day Change ($)0.01
Day Range102.02–102.7352-Week Range85.50–106.74

As of Thu 07/24/2014 06:57 PM EST | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. UPDATE: Goldman Sachs, Johnson & Johnson report earnings Tuesday

    UPDATE: Goldman Sachs, Johnson & Johnson report earnings Tuesday

  2. UPDATE: Goldman Sachs, Johnson & Johnson are stocks to watch Tuesday

    UPDATE: Goldman Sachs, Johnson & Johnson are stocks to watch Tuesday

  3. J &J's Strong 2Q Led by Pharmaceuticals

    Unexpectedly robust sales of hepatitis C drug Olysio helped lift the drug giant’s pharma segment, while medical devices struggled, says Morningstar’s Damien Conover.

  4. The Friday Five

    This week: Financial-services firms post lukewarm earnings, two tech giants strike a deal, Time Warner turns down a foxy offer, and more.

  5. Research and Markets: Global Market for Biomarkers Report: Cancer, Cardiac, Blood, Endocrine, Infectious Disease and Neurological Disease Markers

    Research and Markets: Global Market for Biomarkers Report: Cancer, Cardiac, Blood, Endocrine, Infectious Disease and Neurological Disease Markers

  6. Research and Markets: Global Patient Monitoring Market Report 2014 - Forecast to 2019

    Research and Markets: Global Patient Monitoring Market Report 2014 - Forecast to 2019

  7. Two rules of thumb for dumping your financial adviser

    Two rules of thumb for dumping your financial adviser

  8. UPDATE: U.S. stocks swing as Yellen speaks

    UPDATE: U.S. stocks swing as Yellen speaks

  9. UPDATE: U.S. stocks: Futures up on J.P. Morgan. Goldman beats

    UPDATE: U.S. stocks: Futures up on J.P. Morgan. Goldman beats

  10. U.S. stocks: Futures await Yellen, Goldman, retail sales

    U.S. stocks: Futures await Yellen, Goldman, retail sales

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.